Preliminary immunohistochemical characterization of a monoclonal antibody (pro:4-216) prepared from human prostate cancer nuclear matrix proteins
Open Access
- 30 November 1997
- Vol. 50 (5) , 800-808
- https://doi.org/10.1016/s0090-4295(97)00337-3
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The Clinical Usefulness of Prostate Specific Antigen: Update 1994Journal of Urology, 1994
- Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 MenJournal of Urology, 1994
- Cancer statistics, 1994CA: A Cancer Journal for Clinicians, 1994
- SERUM PSA AFTER ANATOMIC RADICAL PROSTATECTOMYUrologic Clinics of North America, 1993
- Use of nuclear morphometry, gleason histologic scoring, clinical stage, and age to predict disease-free survival among patients with prostate cancerCancer, 1992
- Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate CancerNew England Journal of Medicine, 1991
- A Comparison of Nuclear Morphometry and Gleason Grade as a Predictor of Prognosis in Stage A2 Prostate Cancer: A Critical AnalysisJournal of Urology, 1989
- Nuclear roundness factor. A predictor of progression in untreated stage A2 prostate cancerCancer, 1984
- Silver staining of proteins in polyacrylamide gelsAnalytical Biochemistry, 1981
- Antibodies to major histocompatibility antigens produced by hybrid cell linesNature, 1977